Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
RXRX has reported updated data from its ELUCIDATE and TUPELO trials, but the stock has failed to mount a sustained rally. The ELUCIDATE update provides just an additional 10 patients of data treated ...
Halo Infinite remains to be on the top of gamers' minds despite all the reworks and delays the game has gone through. Although Xbox and developer 343 Industries have shown a few trailers and little ...
The Arrowverse's Crisis on Infinite Earths crossover has officially wrapped. Unlike previous crossovers, Crisis on Infinite Earths not only features heroes from across The CW's Arrowverse, but also a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results